Company / Operating Margin
CHINA PHARMA HOLDINGS, INC. Operating Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
-78.2%
FY2025
5-year range
-78.2% / -23.7%
FY2021-FY2025
Trend
-99.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Margin has fluctuated over the past 10 years, ranging from -186.8% in FY2020 to -23.7% in FY2021.
Based on SEC 10-K filings.
-78.2% in FY2025 with a 5-year CAGR of +108.7%.
Declined from -39.3% to -78.2% over the past 2 years.
Operating Margin over time
Growth rates
- 3-Year Change
- -34.4pp
- 5-Year Change
- +108.7pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, operating margin decreased 99.1% year-over-year.
- Peak operating margin was recorded in FY2021.
- Lowest operating margin in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score -0.44 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -78.2% | -99.1% |
| FY2024 | -39.3% | +0.0% |
| FY2023 | -39.3% | +10.4% |
| FY2022 | -43.8% | -84.5% |
| FY2021 | -23.7% | +87.3% |
| FY2020 | -186.8% | -120.5% |
| FY2019 | -84.7% | +40.1% |
| FY2018 | -141.4% | -169.9% |
| FY2017 | -52.4% | +25.4% |
| FY2016 | -70.3% | +59.9% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026